Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep7 | Adrenal cortex | ECE2015

New onset sarcoidosis after remission of Cushing's syndrome

Canturk Zeynep , Selek Alev , Baris Serap , Cetinarslan Berrin , Tarkun Ilhan , Akyay Zeynep

Introduction: Glucocorticoids, even endogenous or exogenous, suppress the inflammatory response therefore they are the most preferred treatment options in inflammatory diseases. Persistent hypercortisolism induces lymphopenia and lymphoid tissue atrophy. Excessive endogenous hypercortisolism might mask the active inflammatory disease. Rebound immune modulation may occur after Cushing’s syndrome (CS) remission, leading to the new onset of autoimmune diseases.<p class="...

ea0037ep722 | Pituitary: clinical | ECE2015

A rare adventure of a lymphocytic hypophysitis

Canturk Zeynep , Selek Alev , Cetinarslan Berrin , Tarkun Ilhan , Akyay Zeynep , Cabuk Burak , Ceylan Savas

Introduction: Lymphocytic hypophysitis is a rare endocrine disease involving lymphocytic infiltration and chronic pituitary inflammation. It may result in significant morbidity by loss of pituitary functions and neurological deficits. Pituitary abscess is another rare disease which may be associated with underlying parasellar pathology. Here, we report a case of lymphocytic hypophysitis diagnosed with a pituitary abscess and recurrent suprasellar involvement after surgery....

ea0037ep845 | Thyroid cancer | ECE2015

Malignancy risk of thyroid nodules with repeated ‘atypia of undetermined significance/follicular lesion of undetermined significance' diagnosis

Cetinarslan Berrin , Selek Alev , Kivrakoglu Emine , Canturk Zeynep , Tarkun Ilhan , Temiz Duygu , Akyay Zeynep

Introduction: ‘Atypia of undetermined significance/follicular lesion of undetermined significance’ (AUS/FLUS) is a heterogeneous diagnostic thyroid fine needle aspiration biopsy (FNAB) category. AUS/FLUS is comprised of cases that cannot be definitively diagnosed as benign, suspicious for/consistent with neoplasm, suspicious for malignancy or malignant. The recommended management strategy for these cases is to perform a repeat FNAB after an appropriate time course. A...

ea0056gp108 | Diabetes Translational | ECE2018

The effect of GLP-1 agonist treatment on serum betatrophin levels and comparison with insülin treatment in type 2 diabetes mellitus patients

Tarkun Ilhan , Cakmak Yagmur , Akyay Zeynep , Selek Alev , Canturk Zeynep , Cetinarslan Berrin

Objective: Insulin insufficiency which is the result of deficiency of β-cells is the common feature for all types of diabetes. Therefore protection of functional β-cell mass is the keystone of diabetes treatment. Betatrophin, a newly determined hormone, has been identified as a potent stimulator that increases the production and expansion of β-cells in mice. However, very little is known about the physiological role of betatrophin in h...